Dr. Munshi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
303 E Superior Ave
Lurie 3-117
Chicago, IL 60611Phone+1 312-503-2301
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2000 - 2002
University of WashingtonResidency, Internal Medicine, 1996 - 1999
Harvard Medical SchoolClass of 1996
Certifications & Licensure
IL State Medical License 2000 - 2026
MI State Medical License 1999 - 2003- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2012
Publications & Presentations
PubMed
- 27 citationsPreclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies.Thao Pham, Mario A. Shields, Christina Spaulding, Daniel R. Principe, Bo Li
Cancers. 2021-01-25 - 74 citationsContribution of Epithelial-to-Mesenchymal Transition and Cancer Stem Cells to Pancreatic Cancer ProgressionSeth B. Krantz, Mario A. Shields, Surabhi Dangi-Garimella, Hidayatullah G. Munshi, David J. Bentrem
The Journal of Surgical Research. 2012-03-01 - 1 citationsGlandular metastases from renal cell carcinoma show poor clinical responses to immune checkpoint inhibition but durable responses to angiogenesis inhibitorsDaniel R. Principe, Brian C Schulte, Suneel D. Kamath, Hidayatullah G. Munshi
BMJ Case Reports. 2021-06-22
Press Mentions
Combination Therapy May Improve Treatment Response in Pancreatic CancerOctober 10th, 2024- Northwestern Selected as Home for Journal of Clinical Investigation; McNally to Serve as Editor-in-ChiefDecember 14th, 2021
- Loss of Sirt2 Increases and Prolongs a Caerulein-Induced Pancreatitis Permissive Phenotype and Induces Spontaneous Oncogenic Kras Mutations in MiceNovember 7th, 2018
Grant Support
- Targeting Stromal Reaction In Pancreatic Cancer To Overcome Chemo-ResistanceVeterans Affairs2012
- Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer InvasionNational Cancer Institute2011–2012
- Fibrosis-Protease Cross-Talk Regulating Pancreatic Cancer InvasionNational Cancer Institute2008–2010
- Cadherin-Mediated Regulation Of MMPS In Oral CancerNational Cancer Institute2003–2007
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
